PAPER Lezoualc'h F, Engert S, Berning B, Behl C

Corticotropin-releasing hormone-mediated neuroprotection against oxidative stress is associated with the increased release of non-amyloidogenic amyloid beta precursor protein and with the suppression of nuclear factor-kappaB.

Mol Endocrinol. 2000 Jan;14(1):147-59. PubMed.

PAPER Siman R, Reaume AG, Savage MJ, Trusko S, Lin YG, Scott RW, Flood DG

Presenilin-1 P264L knock-in mutation: differential effects on abeta production, amyloid deposition, and neuronal vulnerability.

J Neurosci. 2000 Dec 1;20(23):8717-26. PubMed.

PAPER García-Jiménez A, Cowburn RF, Ohm TG, Bogdanovic N, Winblad B, Fastbom J

Quantitative autoradiography of [3H]forskolin binding sites in post-mortem brain staged for Alzheimer's disease neurofibrillary changes and amyloid deposits.

Brain Res. 1999 Dec 11;850(1-2):104-17. PubMed.

PAPER Monk D, Brodaty H

Use of estrogens for the prevention and treatment of Alzheimer's disease.

Dement Geriatr Cogn Disord. 2000 Jan-Feb;11(1):1-10. PubMed.

PAPER Scherder EJ, Bouma A

Acute versus chronic pain experience in Alzheimer's disease. a new questionnaire.

Dement Geriatr Cogn Disord. 2000 Jan-Feb;11(1):11-6. PubMed.

PAPER Imbimbo BP, Troetel WM, Martelli P, Lucchelli F

A 6-month, double-blind, placebo-controlled trial of eptastigmine in Alzheimer's disease.

Dement Geriatr Cogn Disord. 2000 Jan-Feb;11(1):17-24. PubMed.

PAPER Licastro F, Masliah E, Pedrini S, Thal LJ

Blood levels of alpha-1-antichymotrypsin and risk factors for Alzheimer's disease: effects of gender and apolipoprotein E genotype.

Dement Geriatr Cogn Disord. 2000 Jan-Feb;11(1):25-8. PubMed.

PAPER Lehtovirta M, Partanen J, Könönen M, Hiltunen J, Helisalmi S, Hartikainen P, Riekkinen P, Soininen H

A longitudinal quantitative EEG study of Alzheimer's disease: relation to apolipoprotein E polymorphism.

Dement Geriatr Cogn Disord. 2000 Jan-Feb;11(1):29-35. PubMed.

PAPER Mosek A, Yust I, Treves TA, Vardinon N, Korczyn AD, Chapman J

Dementia and antiphospholipid antibodies.

Dement Geriatr Cogn Disord. 2000 Jan-Feb;11(1):36-8. PubMed.

PAPER Kazui H, Hashimoto M, Hirono N, Imamura T, Tanimukai S, Hanihara T, Ikeda M, Komori K, Ikejiri Y, Mori E

A study of remote memory impairment in Alzheimer's disease by using the family line test.

Dement Geriatr Cogn Disord. 2000 Jan-Feb;11(1):53-8. PubMed.

PAPER Lindahl U

What else can 'Heparin' do?

Haemostasis. 1999 Dec;29 Suppl S1:38-47. PubMed.

PAPER Greene RA

Cerebral blood flow.

Fertil Steril. 2000 Jan;73(1):143. PubMed.

PAPER Zhuo M, Holtzman DM, Li Y, Osaka H, DeMaro J, Jacquin M, Bu G

Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation.

J Neurosci. 2000 Jan 15;20(2):542-9. PubMed.

PAPER Weiss C, Preston AR, Oh MM, Schwarz RD, Welty D, Disterhoft JF

The M1 muscarinic agonist CI-1017 facilitates trace eyeblink conditioning in aging rabbits and increases the excitability of CA1 pyramidal neurons.

J Neurosci. 2000 Jan 15;20(2):783-90. PubMed.

PAPER Ramamurthy B, Höök P, Larsson L

An overview of carbohydrate-protein interactions with specific reference to myosin and ageing.

Acta Physiol Scand. 1999 Dec;167(4):327-9. PubMed.